AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteCasopitant mesylate is the mesylate salt of a centrally-acting neurokinin 1 (NK1) receptor antagonist with antidepressant and antiemetic activities.
More Information Supplier PageCasopitant mesylate is the mesylate salt of a centrally-acting neurokinin 1 (NK1) receptor antagonist with antidepressant and antiemetic activities.
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW788388 is a potent, orally active and selective inhibitor of transforming growth factor beta receptor I (TGF-??R1) (activin receptor-like kinase 5, ALK5).
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW791343 HCl acts as a negative allosteric modulator of human P2X7 (pIC50 = 6.9 – 7.2) and a positive allosteric modulator of rat P2X7.
More Information Supplier PageGW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageGW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageGW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageGW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageGW843682X is a selective inhibitor of polo-like kinase 1 (PLK1) and polo-like kinase 3 (PLK3) (IC50 values are 2.2 and 9.1 nM respectively).
More Information Supplier PageGW843682X is a selective inhibitor of polo-like kinase 1 (PLK1) and polo-like kinase 3 (PLK3) (IC50 values are 2.2 and 9.1 nM respectively).
More Information Supplier PageGW843682X is a selective inhibitor of polo-like kinase 1 (PLK1) and polo-like kinase 3 (PLK3) (IC50 values are 2.2 and 9.1 nM respectively).
More Information Supplier PageGW843682X is a selective inhibitor of polo-like kinase 1 (PLK1) and polo-like kinase 3 (PLK3) (IC50 values are 2.2 and 9.1 nM respectively).
More Information Supplier PageGW 9508 is a cell-permeable aminophenylpropanoate that acts as a potent and selective agonist for the G-protein coupled receptor (GPCR) GRP40/FFA1 receptor (EC50 ?50 nM) with reduced activity towards family members GRP120 (EC50 ?3.5 ??M), GRP41/GRP43 (EC50 >50 ??M), as well as a panel of eight other free fatty acid (FFA) and prostaglandin receptors.
More Information Supplier PageGW 9508 is a cell-permeable aminophenylpropanoate that acts as a potent and selective agonist for the G-protein coupled receptor (GPCR) GRP40/FFA1 receptor (EC50 ?50 nM) with reduced activity towards family members GRP120 (EC50 ?3.5 ??M), GRP41/GRP43 (EC50 >50 ??M), as well as a panel of eight other free fatty acid (FFA) and prostaglandin receptors.
More Information Supplier PageGW 9508 is a cell-permeable aminophenylpropanoate that acts as a potent and selective agonist for the G-protein coupled receptor (GPCR) GRP40/FFA1 receptor (EC50 ?50 nM) with reduced activity towards family members GRP120 (EC50 ?3.5 ??M), GRP41/GRP43 (EC50 >50 ??M), as well as a panel of eight other free fatty acid (FFA) and prostaglandin receptors.
More Information Supplier PageGW 9508 is a cell-permeable aminophenylpropanoate that acts as a potent and selective agonist for the G-protein coupled receptor (GPCR) GRP40/FFA1 receptor (EC50 ?50 nM) with reduced activity towards family members GRP120 (EC50 ?3.5 ??M), GRP41/GRP43 (EC50 >50 ??M), as well as a panel of eight other free fatty acid (FFA) and prostaglandin receptors.
More Information Supplier PageGYKI-52466 dihydrochloride is selective non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 ??M for AMPA- , kainate- and NMDA-induced responses respectively).
More Information Supplier PageGYKI-52466 dihydrochloride is selective non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 ??M for AMPA- , kainate- and NMDA-induced responses respectively).
More Information Supplier PageGYKI-52466 dihydrochloride is selective non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 ??M for AMPA- , kainate- and NMDA-induced responses respectively).
More Information Supplier PageGYKI-52466 dihydrochloride is selective non-competitive AMPA receptor antagonist (IC50 values are 10-20, ~ 450 and >> 50 ??M for AMPA- , kainate- and NMDA-induced responses respectively).
More Information Supplier PageGynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum. The increase of SGOT, SGPT activities in CCl4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio.
More Information Supplier PageGynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum. The increase of SGOT, SGPT activities in CCl4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio.
More Information Supplier PageGynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum. The increase of SGOT, SGPT activities in CCl4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio.
More Information Supplier PageGynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum. The increase of SGOT, SGPT activities in CCl4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio.
More Information Supplier PageGynostemma Extract is a saponins extract derived from the Gynostemma pentaphyllum. The increase of SGOT, SGPT activities in CCl4 liver injury were significantly reduced by treatment with Gypenoside. It also elevated the A/G ratio.
More Information Supplier PageGZ-793A is a selective inhibitor of vesicular monoamine transporter 2 (VMAT2), which transports the monoamine neurotransmitters from cellular cytosol into synaptic vesicles.
More Information Supplier PageGZ-793A is a selective inhibitor of vesicular monoamine transporter 2 (VMAT2), which transports the monoamine neurotransmitters from cellular cytosol into synaptic vesicles.
More Information Supplier PageGZ-793A is a selective inhibitor of vesicular monoamine transporter 2 (VMAT2), which transports the monoamine neurotransmitters from cellular cytosol into synaptic vesicles.
More Information Supplier PageH 89 dihydrochloride is a cell-permeable, selective, reversible, ATP-competitive and potent inhibitor of protein kinase.
More Information Supplier PageH 89 dihydrochloride is a cell-permeable, selective, reversible, ATP-competitive and potent inhibitor of protein kinase.
More Information Supplier PageH 89 dihydrochloride is a cell-permeable, selective, reversible, ATP-competitive and potent inhibitor of protein kinase.
More Information Supplier PageH 89 dihydrochloride is a cell-permeable, selective, reversible, ATP-competitive and potent inhibitor of protein kinase.
More Information Supplier PageH-1152, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.
More Information Supplier PageH-1152, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.
More Information Supplier PageH-1152, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.
More Information Supplier PageH-1152 dihydrochloride, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.
More Information Supplier PageH-1152 dihydrochloride, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.
More Information Supplier PageH-1152 dihydrochloride, an isoquinolinesulfonamide derivative, is a more specific, stronger and membrane-permeable inhibitor of Rho-kinase with a Ki value of 1.6 nM, but poor inhibitor of other serine/threonine kinases.
More Information Supplier PageHA-1077 inhibits vascular smooth muscle contraction by acting as an intracellular Ca2+ antagonist.
More Information Supplier PageHA-1077 inhibits vascular smooth muscle contraction by acting as an intracellular Ca2+ antagonist.
More Information Supplier Page
